Suboxone Suboxone 20.5 Sublingual Tablet
1 INDICATIONS AND USAGE SUBOXONE sublingual tablet is indicated for the maintenance treatment of opioid dependence. SUBOXONE sublingual tablet should be used as part of a complete treatment plan that includes counseling and psychosocial support. SUBOXONE sublingual tablet contains buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for the maintenance treatment of opioid dependence. ( 1 ) SUBOXONE sublingual tablet should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )
Reckitt Benckiser Pharmaceuticals Inc
HEXAGON ORANGE N2
N2 HEXAGON ORANGE
Related Pills
Suboxone 82 Sublingual Tablet
Reckitt Benckiser Pharmaceuticals Inc
Suboxone Suboxone 20.5 Sublingual Tablet
Reckitt Benckiser Pharmaceuticals Inc
Buprenorphine 2 MG Naloxone 0.5 MG Sublingual Tablet
hi-tech pharmacal co. inc.
buprenorphine hydrochloride tablet
hi-tech pharmacal co., inc.
telmisartan 80 MG Oral Tablet
Amneal Pharmaceuticals of New York LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED / STORAGE AND HANDLING SUBOXONE sublingual tablet is an uncoated hexagonal orange tablet, debossed with an alphanumeric word identifying the product and strength (“N2” and “N8” on 2 mg and 8 mg tablets respectively), supplied in white HDPE bottles: NDC 12496-1283-2 (buprenorphine 2 mgand naloxone 0.5 mg/sublingual tablet; content expressed in terms of free base, equivalent to 2.16 mg buprenorphine hydrochloride USP and 0.61 mg naloxone hydrochloride dihydrate USP) - 30 tablets per bottle NDC 12496-1306-2 (buprenorphine 8 mg and naloxone 2 mg/sublingual tablet; content expressed in terms of free base, equivalent to 8.64 mg buprenorphine hydrochloride USP and 2.44 mg naloxone hydrochloride dihydrate USP) - 30 tablets per bottle Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Store SUBOXONE sublingual tablets securely and dispose of properly [see Patient Counseling Information ( 17 )] .
More pills like HEXAGON N2